Startpage »
Projects »
Publications »
Ortelius classification »
Help »
SIGMA-1 RECEPTOR AS A NOVEL DRUG TARGET IN DIABETES-INDUCED NON-RETINAL OCULAR COMPLICATIONS
Help
Print
Here you can view and search the projects funded by NKFI since 2004
Back »
Details of project
Identifier
135398
Type
K
Principal investigator
Fekete, Andrea
Title in Hungarian
A Sigma-1 receptor, mint új gyógyszertámadáspont a diabéteszes szemészeti szövődmények kezelésében
Title in English
SIGMA-1 RECEPTOR AS A NOVEL DRUG TARGET IN DIABETES-INDUCED NON-RETINAL OCULAR COMPLICATIONS
Keywords in Hungarian
Sigma-1 receptor, diabetes, corneal dysfunction, fibrózis
Keywords in English
Sigma-1 receptor, diabetes, corneal dysfunction, fibrosis
Discipline
Endocrinology, diabetes, metabolism, toxicology (Council of Medical and Biological Sciences)
40 %
Molecular biology (Council of Medical and Biological Sciences)
30 %
Ortelius classification:
Molecular markers and recognition
Sensory systems (e.g. visual system, auditory system) (Council of Medical and Biological Sciences)
30 %
Panel
Physiology, Pathophysiology, Pharmacology and Endocrinology
Department or equivalent
1st Dept. of Pediatrics (Semmelweis University)
Participants
Czakó, Cecilia
Farkas, Alexandra
Kis, Judit
Kovács, Illés
Lénárt, Lilla
Szabó, Adrienn
Tóth, Ákos
Starting date
2020-11-01
Closing date
2024-10-31
Funding (in million HUF)
47.640
FTE (full time equivalent)
15.85
state
running project
Back »
PUBv2.02 - © National Research, Development And Innovation Office
Security
»
Legal disclaimer
»
Sitemap
»
Impressum
»
Contact
»